Gainers
- TransCode Therapeutics RNAZ inventory moved upwards by 49.2% to $1.12 throughout Tuesday’s after-market session. As we speak’s buying and selling quantity for this safety ended up closing at 2.8 million shares, which is 97.3 p.c of its common quantity over the past 100 days. The corporate’s market cap stands at $14.5 million.
- Quoin Prescribed drugs QNRX inventory moved upwards by 17.46% to $1.95. This safety traded at a quantity of 154.4K shares come shut, making up 134.3% of its common quantity over the past 100 days. The market worth of their excellent shares is at $9.4 million.
- Evoke Pharma EVOK shares moved upwards by 7.42% to $4.34. The corporate’s market cap stands at $14.5 million.
- OKYO Pharma OKYO inventory elevated by 7.14% to $2.7. The market worth of their excellent shares is at $58.7 million.
- Clearside Biomedical CLSD inventory rose 6.37% to $1.5. The market worth of their excellent shares is at $90.2 million.
- MEI Pharma MEIP inventory moved upwards by 5.18% to $0.3. As we speak’s buying and selling quantity for this safety ended up closing at 114.3K shares, which is 9.0 p.c of its common quantity over the past 100 days. The corporate’s market cap stands at $39.9 million.
Losers
- Poseida Therapeutics PSTX shares fell 9.5% to $6.3 throughout Tuesday’s after-market session. The corporate’s market cap stands at $541.4 million.
- Taysha Gene Therapies TSHA shares declined by 9.15% to $1.49. The market worth of their excellent shares is at $93.0 million.
- Imunon IMNN inventory declined by 6.44% to $1.5. The market worth of their excellent shares is at $11.1 million.
- SINTX Applied sciences SINT inventory declined by 6.15% to $8.4. The market worth of their excellent shares is at $4.3 million.
- LumiraDx LMDX shares fell 5.95% to $0.88. The market worth of their excellent shares is at $279.5 million.
- Varex Imaging VREX inventory declined by 5.78% to $20.25. The corporate’s market cap stands at $811.7 million. The corporate’s, Q1 earnings got here out right this moment.
See Additionally: www.benzinga.com/cash/best-healthcare-stocks/
This text was generated by Benzinga’s automated content material engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
